Posterior mandible reconstruction using cerabone® plus, permamem® and mucoderm® – A case report

Dr. Marko Blašković

The presented case describes the rehabilitation of a challenging extended edentulous site in the posterior lower jaw, using state-of the-art bone regeneration- and soft tissue management techniques, with the goal to bring back the patient a long-term stable dentition.

INITIAL SITUATION

A female patient (66 years old) came to the clinic requesting a periodontal treatment. The patient was in healthy condition, without taking medication and was a non-smoker. She was already missing tooth #36, #37 and #25 (Fig. 1 and 2). After initial periodontal treatment, revaluation and maintenance therapy, the patient requested to restore the missing teeth. The tooth gap at position #36 and #37 impaired the patient’s ability to chew and was therefore primarily of functional concern.

TREATMENT PLANNING

After CBCT assessment (Fig. 3 and 4), implant placement and simultaneous GBR was proposed to the patient. Since three defects were expected to occur around the implant (buccal and lingual dehiscence and a small two to three millimetre vertical defect on the distal side of the implant), a non-resorbable membrane (permamem®) was planned to be used, which would provide sufficient form stability and thus optimal conditions for complete defect resolution. A combination of autogenous graft and a volume stable bone substitute (cerabone® plus) were planned to be used as a bone graft. The autogenous bone would be collected with a bone scraper form the retromolar region adjacent to the defect site. Finally, a soft tissue management procedure will be planned prior to the restorative work.

SURGICAL AND PROSTHETIC PROCEDURE

Implant placement and GBR

A full thickness flap was raised with a vertical incision. The incision was elongated in the distal direction in order to include the retromolar region (Fig. 5). Then the patient underwent an atraumatic extraction of tooth number #38 as the tooth showed a poor perio prognosis with deep pockets and resorption more than half to two-thirds of the root length. Thereafter, a 4.1 x 10 BLT Straumann bone level implant was placed and, as expected, three peri-implant defects were present (Fig. 6 – 8). Cortical perforations were performed on the buccal aspect. The membrane (permamem®, 20 x 30 mm) was trimmed according to the defect size and initially stabilised in the apical part of the membrane. Subsequently a bone graft was placed: for the first layer only autogenous bone was used, which was harvested from the retromolar area (Fig. 9 – 11) and packed around the exposed implant surface (Fig. 12). For the second layer a mixture of 50% autogenous bone and 50% cerabone® plus was used (Fig. 13). The second layer was used on top of the first layer. Afterwards, the membrane was placed over the graft, tightly adapted and completely stabilized with additional bone pins (Fig. 14). 6.0 monofilament resorbable mattress sutures were used to achieve primary and tension-free wound closure (Fig. 15).

Re-entry

After six months of healing time, the treated site presented with excellent soft tissue healing (Fig. 19) and was reopened with a full thickness flap and the non-resorbable membrane was removed (Fig. 16 and 17). The re-entered site showed optimal graft integration with a sufficient bone gain both in horizontal and vertical dimension (Fig. 17 and 18). However, displacement of the mucogingival line and a reduced width of the keratinized mucosa was evident (Fig. 19).

Soft tissue management

Two months after re-entry and membrane removal, a widening of the keratinized mucosa was performed: an apically positioned flap was combined with a free gingival graft. The graft was taken from the distal part of the palate (Fig. 20 – 22).

Two months after the third procedure, a sufficient gain of keratinized tissue could be achieved (Fig. 23 and 24). Then, the implant uncovering procedure was performed with simultaneous peri-implant soft tissue augmentation. In order to avoid a second harvesting procedure from the palate, a porcine acellular dermal matrix (mucoderm®) was used instead. The matrix was hydrated in sterile saline solution and placed at the buccal aspect. The marginal soft tissues were sutured using 6.0 non-resorbable monofilament sutures (Fig. 25 – 27).

Six weeks after healing abutment placement, a provisional crown was fabricated. The provisional crown was used to condition the soft tissue and obtain a more natural emergence profile (Fig. 28 – 31).

FINAL SCORE

A screw retained monolithic ceramic zirconia crown (on Variobase link) was created as definitive restoration (Fig. 32). The bone augmentation procedure allowed the fulfilment of two important goals: 1) prosthetically driven implant placement, which enables fabrication of a screw retained crown and 2) bony walls of adequate thickness (minimum of two millimetres) surrounding the implant. Soft tissue augmentation procedures recreated the peri-implant soft tissue of adequate quality (two millimetres keratinized soft tissue) and thickness (at least two millimetres), which has a positive long-term effect providing peri-implant soft tissue and marginal bone stability and facilitating the maintenance of oral hygiene. 

CONCLUSION

The fulfilment of all aforementioned points is especially important in periodontally compromised patients, who have an increased risk for developing peri-implantitis. A detailed clinical diagnosis and treatment planning together with the selection of suitable biomaterials is key for achieving a satisfying outcome both on a functional and aesthetic level.

MORE CLINICAL CASES

  • CASO CLINICO DEL:

    Dr. Devorah Schwartz-Arad

    Ridge preservation in the aesthetic zone using CTG and cerabone® plus
  • CASO CLINICO DEL:

  • CASO CLINICO DEL:

  • CASO CLINICO DEL:

    Prof. Anton Sculean, Dr. Marius Steigmann, Dr. Dragana Rakasevic, Dr. Miguel Stanley

    Biofunctionalization with hyaluronic acid –
    impact on dental regeneration

  • CASO CLINICO DEL:

    Dr. Rafael Block Veras

    cerabone® plus for immediate implantation and sinus augmentation
  • CASO CLINICO DEL:

    Dr. Stavros Pelekanos

    cerabone® plus for gap augmentation around an immediate implant
  • CASO CLINICO DEL:

    Dr. Laszlo Parkanyi

    Bone grafting in present days – how cerabone® plus can make the difference 
  • CASO CLINICO DEL:

    Dr. Andoni Jones

    cerabone® plus in regenerative implantology
  • CASO CLINICO DEL:

    Prof. Dr. Sofia Aroca, Paris, France

    Bone regeneration at two peri-implantitis affected implants using cerabone® plus and Jason® membrane
  • CASO CLINICO DEL:

    Dr. Rafael Block Veras, Berlin, Germany

    Lateral sinus floor augmentation using cerabone® plus
  • CASO CLINICO DEL:

    Dr. Stuardo Valenzuela, Coquimbo, Chile

    Immediate implant placement using cerabone® plus
  • CASO CLINICO DEL:

    Dr. Yusuf Alshafi, London, UK

    Implant placement and bone defect augmentation in the posterior mandible
  • CASO CLINICO DEL:

    Dr. Rafael Block Veras, Berlin, Germany

    Immediate implantation in the posterior mandible
  • CASO CLINICO DEL:

    Dr. Damir Jelusic, Opatija, Croatia

    Extraction site management using cerabone® plus and Jason® membrane
  • CASO CLINICO DEL:

    Dr. Viktor Kalenchuk, Chernivtsi, Ukraine

    GBR at two dental implants using cerabone® plus and Jason® membrane
  • CASO CLINICO DEL:

    Dr. Michael R. Norton

    Insights into a new generation of biomaterials – cerabone® plus
  • CASO CLINICO DEL:

    Dr. Massimo Frosecchi

    GBR at an implant site using cerabone® plus and mucoderm®
  • CASO CLINICO DEL:

    Dr. David Palombo

    cerabone® plus for treatment of an aesthetic implant fenestration
  • CASO CLINICO DEL:

    Dr. Andoni Jones, Dublin, Ireland

    Implant placement and GBR in the aesthetic zone using cerabone® plus and Jason® membrane
  • CASO CLINICO DEL:

    Dr. Filippo Fontana, Milan, Italy

    cerabone® plus for bone augmentation around an immediately placed implant
  • CASO CLINICO DEL:

    Dr. Carlo De Annuntiis, Rome, Italy

    Hard- and soft tissue augmentation around an immediately placed implant using cerabone® plus and mucoderm®
  • CASO CLINICO DEL:

    Dr. Andoni Jones, Dublin, Ireland

    CERABONE® PLUS FOR BONE AUGMENTATION AND SOFT TISSUE SUPPORT IN THE AESTHETIC ZONE
  • CASO CLINICO DEL:

    Dr. Viktor Kalenchuk, Chernivtsi, Ukraine

    PERI-IMPLANT BONE AUGMENTATION WITH CERABONE® PLUS AND JASON® MEMBRANE
  • CASO CLINICO DEL:

    Dr. Michael Norton, London, UK

    CERABONE® PLUS FOR BONE AUGMENTATION OF A PERI-IMPLANTITIS-AFFECTED SITE
  • CASO CLINICO DEL:

    Dr. László Párkányi, Szeged, Hungary

    HORIZONTAL BONE AUGMENTATION USING CERABONE® PLUS AND JASON® MEMBRANE
  • CASO CLINICO DEL:

    Dr. Javier Sanz Esporrin, Madrid, Spain

    REGENERATION OF AN INTRABONY DEFECT WITH CERABONE® PLUS 
  • CASO CLINICO DEL:

    Dr. Rafael Block Veras, Berlin, Germany

    IMMEDIATE IMPLANT PLACEMENT AND PERI-IMPLANT BONE AUGMENTATION WITH CERABONE® PLUS 
  • CASO CLINICO DEL:

    Dr. Serhat Aslan, Izmir, Turkey

    REGENERATION OF AN INTRABONY DEFECT WITH CERABONE® PLUS AND JASON® MEMBRANE